🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to: 1. Compare two study patches having mi...
Status
Completed
Location
Prism Research, LLC
Start Date
2009-12
Trial ID
NCT01381796
Treatments Being Tested
To access the single-dose oral bioequivalence of sumatriptan succinate 100 ...
Status
Completed
Location
Ranbaxy CPU
Start Date
2008-07
Trial ID
NCT00872274
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-11
Trial ID
NCT00648466
Treatments Being Tested
An open label, bioequivalence study of sumatriptan succinate 100 mg tablets...
Status
Completed
Location
Ranbaxy CPU
Start Date
2008-07
Trial ID
NCT00872924
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-11
Trial ID
NCT00650247
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Biovail Contract Research
Start Date
2003-03
Trial ID
NCT00847405
Treatments Being Tested
The objective of this study was to compare the relative bioavailability of ...
Status
Completed
Location
BA Research India Limited
Start Date
2005-07
Trial ID
NCT01269281
Treatments Being Tested
The primary objective is to compare the pharmacokinetics (PK) of NP101 with...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2007-11
Trial ID
NCT00546650
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2004-08
Trial ID
NCT00846885
Treatments Being Tested
Study KCC-SMT-002, is a Phase 1, single-site, open-label, non-randomized, c...
Status
Completed
Location
Carolina Phase 1 Research
Start Date
2018-01-17
Trial ID
NCT03229798
Treatments Being Tested